Dr. Jeremy Bergamo, MD
What this data tells you about Dr. Bergamo
Dr. Jeremy Bergamo is an urology physician in Sarasota, FL, with 9 years in practice. Based on federal Medicare data, Dr. Bergamo performed 7,616 Medicare services across 2,796 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bergamo received a total of $2,870 from 29 pharmaceutical and/or device companies across 88 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bergamo is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 3,850 | $2 | $9 |
| Office visit, established patient (30-39 min) | 661 | $88 | $320 |
| Bladder ultrasound after voiding | 576 | $8 | $60 |
| Office visit, established patient (20-29 min) | 487 | $64 | $216 |
| Urinalysis, manual | 353 | $3 | $11 |
| Automated urinalysis | 277 | $2 | $11 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 187 | $135 | $685 |
| Drug injection, under skin or into muscle | 173 | $10 | $71 |
| Limited ultrasound scan behind abdominal cavity | 162 | $41 | $343 |
| New patient office visit (45-59 min) | 113 | $116 | $501 |
| Instillation of anti-cancer drug into bladder | 98 | $66 | $363 |
| Simple change of bladder tube | 71 | $73 | $353 |
| Diagnostic exam of bladder and urethra using an endoscope | 70 | $175 | $668 |
| Office visit, established patient (10-19 min) | 69 | $41 | $129 |
| Simple insertion of temporary bladder tube | 67 | $44 | $238 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 64 | $24 | $107 |
| Imaging of urinary tract following injection of a contrast agent | 61 | $19 | $69 |
| New patient office visit (30-44 min) | 46 | $73 | $325 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 39 | $241 | $795 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 37 | $334 | $1,315 |
| Initial hospital admission, moderate complexity | 33 | $103 | $421 |
| Insertion of stent in ureter using an endoscope | 31 | $100 | $526 |
| Ultrasound scan of pelvic region through rectum | 25 | $23 | $243 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 20 | $64 | $311 |
| Dilation of urethra using an endoscope | 18 | $120 | $484 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 16 | $15 | $61 |
| Biopsy of prostate gland | 12 | $89 | $458 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
2.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Bergamo is a clinical cardiology specialist, with above-average Medicare volume (top 16% in FL), and low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Bergamo experienced with bcg treatment for bladder cancer?
Does Dr. Bergamo receive payments from pharmaceutical companies?
How do Dr. Bergamo's costs compare to other urology physicians in Sarasota?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology